Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease

Inflammatory Bowel Diseases

Volumn 22, Issue 9, 2016, Pages 2182-2190

  Vaughn, Byron P ^a   Vatanen, Tommi ^b,c   Allegretti, Jessica R ^d   Bai, Aiping ^a   Xavier, Ramnik J ^b,e   Korzenik, Joshua ^d   Gevers, Dirk ^b,f   Ting, Amanda ^a   Robson, Simon C ^a   Moss, Alan C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c AALTO UNIVERSITY   (Finland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f Janssen Human Microbiome Institute at Janssen Research and Development LLC   (United States)

Author keywords

Clinical Trials; microbiology of IBD; rohn's disease

Indexed keywords

STEROID;

ABDOMINAL CRAMP; ACIDAMINOCOCCACEAE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; CONSTIPATION; CROHN DISEASE; ENTEROBACTERIACEAE; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FEMALE; FEVER; FUSOBACTERIACEAE; HUMAN; INTESTINE FLORA; LAMINA PROPRIA; MALE; MICROBIAL DIVERSITY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; STEROID THERAPY; TREATMENT RESPONSE; URTICARIA; CLASSIFICATION; DONOR SELECTION; DYSBIOSIS; FECES; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; REMISSION; T LYMPHOCYTE; UNITED STATES; WHOLE GENOME SEQUENCING; YOUNG ADULT;

ADULT; CROHN DISEASE; DONOR SELECTION; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; INTESTINES; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; T-LYMPHOCYTES; UNITED STATES; WHOLE GENOME SEQUENCING; YOUNG ADULT;

EID: 84983655989     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000893     Document Type: Article

References (40)

1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009; 361:2066-2078.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640.
3. Eckburg PB, Relman DA. The role of microbes in Crohn's disease. Clin Infect Dis. 2007;44:256-262.
4. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014;15:382-392.
5. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.
6. Damman CJ, Miller SI, Surawicz CM, et al. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol. 2012;107:1452-1459.
7. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368:407-415.
8. Grehan MJ, Borody TJ, Leis SM, et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010;44:551-561.
9. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994-1002.
10. Weingarden A, Gonzalez A, Vazquez-Baeza Y, et al. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 2015;3:10.
11. Seekatz AM, Aas J, Gessert CE, et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio. 2014;5:e00893-e00914.
12. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036-1038.
13. Khoruts A, Rank KM, Newman KM, et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2016 Feb 22. pii: S1542-3565(16)00166-X.
14. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102-109.e6.
15. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149:110-118.e4.
16. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
17. Doherty GA, Bennett GC, Cheifetz AS, et al. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Aliment Pharmacol Ther. 2010;31:802-809.
18. Hedin C, van der Gast CJ, Rogers GB, et al. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Gut. 2016;65:944-953.
19. Hamilton MJ, Weingarden AR, Sadowsky MJ, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761-767.
20. Segata N, Waldron L, Ballarini A, et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012;9:811-814.
21. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357-359.
22. Maaten L. Visualizing Data using t-SNE. J Mach Learn Res. 2008:2579-2605.
23. Abubucker S, Segata N, Goll J, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012;8:e1002358.
24. Dimmer EC, Huntley RP, Alam-Faruque Y, et al. The UniProt-GO annotation database in 2011. Nucleic Acids Res. 2012;40:D565-D570.
25. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43: D1049-D1056.
26. Huang Y, Li H, Hu H, et al. Systematic discovery of functional modules and context-specific functional annotation of human genome. Bioinformatics. 2007;23:i222-i229.
27. Zhou X, Kao MC, Wong WH. Transitive functional annotation by shortest-path analysis of gene expression data. Proc Natl Acad Sci U S A. 2002;99:12783-12788.
28. Bergsbaken T, Bevan MJ. Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8(+) T cells responding to infection. Nat Immunol. 2015;16:406-414.
29. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868-1878.
30. Wang Y, Liu XP, Zhao ZB, et al. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease. J Dig Dis. 2011;12:286-294.
31. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203:1701-1711.
32. Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+) FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10:849-859.
33. Yu N, Li X, Song W, et al. CD4(+)CD25 (+)CD127 (low/-) T cells: a more specific Treg population in human peripheral blood. Inflammation. 2012; 35:1773-1780.
34. Bai A, Moss A, Kokkotou E, et al. CD39 and CD161 modulate Th17 responses in Crohn's disease. J Immunol. 2014;193:3366-3377.
35. Suskind DL, Brittnacher MJ, Wahbeh G, et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis. 2015;21:556-563.
36. Cui B, Feng Q, Wang H, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30:51-58.
37. De la Fuente M, Franchi L, Araya D, et al. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol. 2014;304:384-392.
38. Seo SU, Kamada N, Munoz-Planillo R, et al. Distinct commensals induce Interleukin-1beta via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to Injury. Immunity. 2015; 42:744-755.
39. Elliott TR, Hudspith BN, Wu G, et al. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2326-2338.
40. Reshef L, Kovacs A, Ofer A, et al. Pouch inflammation is associated with a decrease in specific bacterial Taxa. Gastroenterology. 2015;149: 718-727.